Episodes: 99
Frequency: Weekly
Rating: 5.0/5.0
Estimated listeners: 100 - 1,000
Listener location: USA
YouTube: 78 subscribers
Publicly listed emails
contact@dualityent.com
hello@incubatecoalition.org
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
John Stanford - Host covering the science, business, policy, and innovation behind the development of medicines and biotechnology.
Patrick Malone - Artificial Intelligence In Drug Discovery, Biotech Investing, Clinical Trials, Regulatory Data, FDA Modernization, And U.s. Biotechnology Competitiveness
Michael Rome - Biotech Venture Capital, Early-stage Drug Development, Biotech Ipos, Mergers And Acquisitions, Capital Formation, Drug Pricing Policy, And Investment In Biotechnology
Jeremy Levin - Small Biotech Innovation, Pharmaceutical Partnerships And Acquisitions, Drug Development, Venture Capital, Drug Pricing, Regulation, And Biotechnology Competitiveness
Sheila Mikhail - Building Biotech Companies, Gene Therapy, Early-stage Investment, University Commercialization, Pharmaceutical Partnerships, Manufacturing Innovation, And Drug Development
Kate Hudson - Research Universities, NIH And NSF Funding, Technology Transfer, Commercialization, Basic Research, Drug Discovery, And U.s. Scientific Competitiveness
Biotech Boom, Drug Lag: Japan's Innovation Paradox
October 15, 2026
Japan has many of the ingredients of a world-class biotechnology ecosystem: leading scientific research, Nobel Prize-winning discoveries, and growing investment. Yet many innovative medicines reach Japanese patients later than in other markets, and some never launch at all.So what explains the gap?In this special Tokyo episode of the Making Medicine Podcast, host John Stanford is joined by Michael Gutbrod, Principal at Santé Ventures, and Marian Nakada, former Vice President of Venture Invest...
Ohio’s Biotech Boom: Gene Therapy, Investment & the Race with China
October 08, 2026
Ohio is emerging as a major U.S. life sciences hub, with growing investment in biotech, gene therapy, biomanufacturing and pharmaceutical innovation. But what does it take to build a competitive biotech ecosystem outside traditional hubs like Boston and San Francisco?In this episode of the Making Medicine Podcast, host John Stanford sits down with Eddie Pauline, President & CEO of Ohio Life Sciences, to explore how Ohio is building its biotech ecosystem—and how decisions involving researc...
AI in Drug Discovery: What Works, What’s Hype & What Comes Next
October 01, 2026
Artificial intelligence could transform drug discovery and biotech, but not necessarily in the ways the biggest AI predictions suggest. Where can AI actually make drug development faster and more efficient, and where does the hype collide with the realities of biology?In this episode of the Making Medicine Podcast, host John Stanford sits down with Dr. Thomas Kaiser, co-founder and Chief Scientific Officer of Avicenna Biosciences and operating partner at DCVC Bio, for a deep dive into AI, mac...
Raising Biotech · Medium booking difficulty · 100 - 1,000 listeners
National Pharmaceutical Congress (NPC) Podcast · High booking difficulty · 100 - 1,000 listeners
Making Medicine is hosted by John Stanford. Its publicly listed emails are contact@dualityent.com and hello@incubatecoalition.org. For guest bookings, the host or producer is usually the best person to reach. Podseeker helps you find direct host and producer contacts and pitch from your own inbox.
The publicly listed emails for Making Medicine: contact@dualityent.com and hello@incubatecoalition.org.
Podseeker estimates Making Medicine reaches 100 to 1,000 listeners per episode. Only the publisher has exact numbers.
Making Medicine typically books industry leaders. Typical guest background: Senior biotech or pharmaceutical executives, successful biotech founders, venture capital investors, physician-scientists, university research leaders, and healthcare-policy experts with direct experience in drug discovery, development, commercialization, investment, or patient access. Common among recent guests: Founded or led biotechnology companies; Held senior leadership roles at major pharmaceutical or life-sciences organizations; Managed therapeutics or biotech investment portfolios. Recent guests include Patrick Malone, Michael Rome, and Jeremy Levin.
High. It mostly books established leaders in its field.
Recent episodes cover Biotechnology, Drug Development, Pharmaceuticals, Healthcare Policy, and Venture Capital. Pitch an idea tied to one of these topics and mention a recent episode.
Publicly listed emails
contact@dualityent.com
hello@incubatecoalition.org
Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings